This report provides a comprehensive analysis of the global anticoagulant and non-anticoagulant rodenticides market, forecasting industry trends and growth through 2032. The study examines the distinction between thrombin-inhibiting anticoagulants and rapid-acting non-anticoagulants across industrial, agricultural, and household applications. By evaluating regional dynamics, competitive landscapes, and key manufacturer strategies, the research identifies emerging opportunities and market drivers. Detailed segmentation by product type and geography offers a nuanced perspective on the evolving global pest control landscape.

Market Overview

The global Anticoagulant and Non-Anticoagulant Rodenticides market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate during the forecast period.

Product Definition and Mechanism of Action

Anticoagulant and non-anticoagulant rodenticides are chemical substances utilized to eliminate rodent pests. The two primary types function as follows:

• Anticoagulant Rodenticides: These chemicals inhibit thrombin activity within rodent pests. This inhibition prevents the pests from coagulating blood normally, leading to uncontrolled bleeding and eventual death. This method requires continuous ingestion over several days to exert its killing effect, resulting in a longer timeframe for pest control.
• Non-Anticoagulant Rodenticides: These achieve rodent control by affecting the nervous system or the metabolic pathways of the pests. These substances typically act more rapidly than anticoagulants.

Usage Note: When utilizing either anticoagulant or non-anticoagulant rodenticides, it is essential to adhere strictly to provided instructions to ensure maximum pest control efficacy and safe application.

Report Scope and Methodology

LP Information, Inc. (LPI) has released the “Anticoagulant and Non-Anticoagulant Rodenticides Industry Forecast,” a research report that evaluates past sales and reviews total global Anticoagulant and Non-Anticoagulant Rodenticides sales in 2025. The report provides a comprehensive analysis of projected sales for the period of 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

This Insight Report offers a detailed examination of the global landscape, highlighting key trends regarding:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• Mergers and Acquisitions (M&A) activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their specific portfolios, capabilities, market entry strategies, market positions, and geographic footprints to provide insight into their unique standing within the accelerating global market. Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the study provides a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

• Anticoagulant
• Non-Anticoagulant

By Application

• Industrial
• Agriculture
• Household Use
• Others

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• UPL Limited
• BASF
• Liphatech
• Bayer Cropscience
• Senestech
• Marusan Pharma Biotech
• Syngenta
• J.T. Eaton
• Neogen Corporation
• PelGar International
• Brizal Quimica
• Impex Europa
• Teikoku Seiyaku
• Anticimex
• Rentokil Initial
• Bell Laboratories
• Abell Pest Control
• Dalian Sanli Shodoku
• Zhejiang Garden Biopharmaceutical

Key Questions Addressed

This report aims to answer the following critical industry questions:

• What is the 10-year outlook for the global Anticoagulant and Non-Anticoagulant Rodenticides market?
• What factors are driving Anticoagulant and Non-Anticoagulant Rodenticides market growth, both globally and by specific region?
• Which technologies are poised for the fastest growth by market and region?
• How do Anticoagulant and Non-Anticoagulant Rodenticides market opportunities vary by end market size?
• How does the Anticoagulant and Non-Anticoagulant Rodenticides market break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Anticoagulant and Non-Anticoagulant Rodenticides by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Anticoagulant and Non-Anticoagulant Rodenticides by Country/Region, 2021, 2025 & 2032

  • 2.2 Anticoagulant and Non-Anticoagulant Rodenticides Segment by Type

    • 2.2.1 Anticoagulant

    • 2.2.2 Non-Anticoagulant

    • 2.2.3 Anticoagulant and Non-Anticoagulant Rodenticides Sales by Type

      • 2.2.3.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Anticoagulant and Non-Anticoagulant Rodenticides Sale Price by Type (2021-2026)

  • 2.3 Anticoagulant and Non-Anticoagulant Rodenticides Segment by Application

    • 2.3.1 Industrial

    • 2.3.2 Agriculture

    • 2.3.3 Household Use

    • 2.3.4 Others

    • 2.3.5 Anticoagulant and Non-Anticoagulant Rodenticides Sales by Application

      • 2.3.5.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Sale Market Share by Application (2021-2026)
      • 2.3.5.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Revenue and Market Share by Application (2021-2026)
      • 2.3.5.3 Global Anticoagulant and Non-Anticoagulant Rodenticides Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Breakdown Data by Company

    • 3.1.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Sales by Company (2021-2026)

    • 3.1.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Sales Market Share by Company (2021-2026)

  • 3.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Revenue by Company (2021-2026)

    • 3.2.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Revenue Market Share by Company (2021-2026)

  • 3.3 Global Anticoagulant and Non-Anticoagulant Rodenticides Sale Price by Company

  • 3.4 Key Manufacturers Anticoagulant and Non-Anticoagulant Rodenticides Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Anticoagulant and Non-Anticoagulant Rodenticides Product Location Distribution

    • 3.4.2 Players Anticoagulant and Non-Anticoagulant Rodenticides Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Anticoagulant and Non-Anticoagulant Rodenticides by Geographic Region

  • 4.1 World Historic Anticoagulant and Non-Anticoagulant Rodenticides Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Anticoagulant and Non-Anticoagulant Rodenticides Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Anticoagulant and Non-Anticoagulant Rodenticides Sales Growth

  • 4.4 APAC Anticoagulant and Non-Anticoagulant Rodenticides Sales Growth

  • 4.5 Europe Anticoagulant and Non-Anticoagulant Rodenticides Sales Growth

  • 4.6 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides Sales Growth

• 5 Americas

  • 5.1 Americas Anticoagulant and Non-Anticoagulant Rodenticides Sales by Country

    • 5.1.1 Americas Anticoagulant and Non-Anticoagulant Rodenticides Sales by Country (2021-2026)

    • 5.1.2 Americas Anticoagulant and Non-Anticoagulant Rodenticides Revenue by Country (2021-2026)

  • 5.2 Americas Anticoagulant and Non-Anticoagulant Rodenticides Sales by Type (2021-2026)

  • 5.3 Americas Anticoagulant and Non-Anticoagulant Rodenticides Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Anticoagulant and Non-Anticoagulant Rodenticides Sales by Region

    • 6.1.1 APAC Anticoagulant and Non-Anticoagulant Rodenticides Sales by Region (2021-2026)

    • 6.1.2 APAC Anticoagulant and Non-Anticoagulant Rodenticides Revenue by Region (2021-2026)

  • 6.2 APAC Anticoagulant and Non-Anticoagulant Rodenticides Sales by Type (2021-2026)

  • 6.3 APAC Anticoagulant and Non-Anticoagulant Rodenticides Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Anticoagulant and Non-Anticoagulant Rodenticides by Country

    • 7.1.1 Europe Anticoagulant and Non-Anticoagulant Rodenticides Sales by Country (2021-2026)

    • 7.1.2 Europe Anticoagulant and Non-Anticoagulant Rodenticides Revenue by Country (2021-2026)

  • 7.2 Europe Anticoagulant and Non-Anticoagulant Rodenticides Sales by Type (2021-2026)

  • 7.3 Europe Anticoagulant and Non-Anticoagulant Rodenticides Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides by Country

    • 8.1.1 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Anticoagulant and Non-Anticoagulant Rodenticides Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Anticoagulant and Non-Anticoagulant Rodenticides

  • 10.3 Manufacturing Process Analysis of Anticoagulant and Non-Anticoagulant Rodenticides

  • 10.4 Industry Chain Structure of Anticoagulant and Non-Anticoagulant Rodenticides

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Anticoagulant and Non-Anticoagulant Rodenticides Distributors

  • 11.3 Anticoagulant and Non-Anticoagulant Rodenticides Customer

• 12 World Forecast Review for Anticoagulant and Non-Anticoagulant Rodenticides by Geographic Region

  • 12.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Market Size Forecast by Region

    • 12.1.1 Global Anticoagulant and Non-Anticoagulant Rodenticides Forecast by Region (2027-2032)

    • 12.1.2 Global Anticoagulant and Non-Anticoagulant Rodenticides Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Anticoagulant and Non-Anticoagulant Rodenticides Forecast by Type (2027-2032)

  • 12.7 Global Anticoagulant and Non-Anticoagulant Rodenticides Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 UPL Limited

    • 13.1.1 UPL Limited Company Information

    • 13.1.2 UPL Limited Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.1.3 UPL Limited Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 UPL Limited Main Business Overview

    • 13.1.5 UPL Limited Latest Developments

  • 13.2 BASF

    • 13.2.1 BASF Company Information

    • 13.2.2 BASF Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.2.3 BASF Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 BASF Main Business Overview

    • 13.2.5 BASF Latest Developments

  • 13.3 Liphatech

    • 13.3.1 Liphatech Company Information

    • 13.3.2 Liphatech Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.3.3 Liphatech Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Liphatech Main Business Overview

    • 13.3.5 Liphatech Latest Developments

  • 13.4 Bayer Cropscience

    • 13.4.1 Bayer Cropscience Company Information

    • 13.4.2 Bayer Cropscience Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.4.3 Bayer Cropscience Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Bayer Cropscience Main Business Overview

    • 13.4.5 Bayer Cropscience Latest Developments

  • 13.5 Senestech

    • 13.5.1 Senestech Company Information

    • 13.5.2 Senestech Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.5.3 Senestech Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 Senestech Main Business Overview

    • 13.5.5 Senestech Latest Developments

  • 13.6 Marusan Pharma Biotech

    • 13.6.1 Marusan Pharma Biotech Company Information

    • 13.6.2 Marusan Pharma Biotech Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.6.3 Marusan Pharma Biotech Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Marusan Pharma Biotech Main Business Overview

    • 13.6.5 Marusan Pharma Biotech Latest Developments

  • 13.7 Syngenta

    • 13.7.1 Syngenta Company Information

    • 13.7.2 Syngenta Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.7.3 Syngenta Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Syngenta Main Business Overview

    • 13.7.5 Syngenta Latest Developments

  • 13.8 J.T. Eaton

    • 13.8.1 J.T. Eaton Company Information

    • 13.8.2 J.T. Eaton Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.8.3 J.T. Eaton Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 J.T. Eaton Main Business Overview

    • 13.8.5 J.T. Eaton Latest Developments

  • 13.9 Neogen Corporation

    • 13.9.1 Neogen Corporation Company Information

    • 13.9.2 Neogen Corporation Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.9.3 Neogen Corporation Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Neogen Corporation Main Business Overview

    • 13.9.5 Neogen Corporation Latest Developments

  • 13.10 PelGar International

    • 13.10.1 PelGar International Company Information

    • 13.10.2 PelGar International Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.10.3 PelGar International Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 PelGar International Main Business Overview

    • 13.10.5 PelGar International Latest Developments

  • 13.11 Brizal Quimica

    • 13.11.1 Brizal Quimica Company Information

    • 13.11.2 Brizal Quimica Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.11.3 Brizal Quimica Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 Brizal Quimica Main Business Overview

    • 13.11.5 Brizal Quimica Latest Developments

  • 13.12 Impex Europa

    • 13.12.1 Impex Europa Company Information

    • 13.12.2 Impex Europa Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.12.3 Impex Europa Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Impex Europa Main Business Overview

    • 13.12.5 Impex Europa Latest Developments

  • 13.13 Teikoku Seiyaku

    • 13.13.1 Teikoku Seiyaku Company Information

    • 13.13.2 Teikoku Seiyaku Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.13.3 Teikoku Seiyaku Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Teikoku Seiyaku Main Business Overview

    • 13.13.5 Teikoku Seiyaku Latest Developments

  • 13.14 Anticimex

    • 13.14.1 Anticimex Company Information

    • 13.14.2 Anticimex Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.14.3 Anticimex Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Anticimex Main Business Overview

    • 13.14.5 Anticimex Latest Developments

  • 13.15 Rentokil Initial

    • 13.15.1 Rentokil Initial Company Information

    • 13.15.2 Rentokil Initial Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.15.3 Rentokil Initial Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Rentokil Initial Main Business Overview

    • 13.15.5 Rentokil Initial Latest Developments

  • 13.16 Bell Laboratories

    • 13.16.1 Bell Laboratories Company Information

    • 13.16.2 Bell Laboratories Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.16.3 Bell Laboratories Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Bell Laboratories Main Business Overview

    • 13.16.5 Bell Laboratories Latest Developments

  • 13.17 Abell Pest Control

    • 13.17.1 Abell Pest Control Company Information

    • 13.17.2 Abell Pest Control Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.17.3 Abell Pest Control Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Abell Pest Control Main Business Overview

    • 13.17.5 Abell Pest Control Latest Developments

  • 13.18 Dalian Sanli Shodoku

    • 13.18.1 Dalian Sanli Shodoku Company Information

    • 13.18.2 Dalian Sanli Shodoku Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.18.3 Dalian Sanli Shodoku Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.18.4 Dalian Sanli Shodoku Main Business Overview

    • 13.18.5 Dalian Sanli Shodoku Latest Developments

  • 13.19 Zhejiang Garden Biopharmaceutical

    • 13.19.1 Zhejiang Garden Biopharmaceutical Company Information

    • 13.19.2 Zhejiang Garden Biopharmaceutical Anticoagulant and Non-Anticoagulant Rodenticides Product Portfolios and Specifications

    • 13.19.3 Zhejiang Garden Biopharmaceutical Anticoagulant and Non-Anticoagulant Rodenticides Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.19.4 Zhejiang Garden Biopharmaceutical Main Business Overview

    • 13.19.5 Zhejiang Garden Biopharmaceutical Latest Developments

• 14 Research Findings and Conclusion